Tizona Therapeutics Appoints Scott Clarke as Chief Executive Officer and Provides Update on Regulatory Milestone for its First-in-Class CD39 program in Cancer

World News: . []

SOUTH SAN FRANCISCO Calif Jan 03 2019 GLOBE NEWSWIRE -- Tizona Therapeutics Inc Tizona a privately-held immunotherapy company announced today that Scott Clarke has joined the company as its chief executive officer Mr Clarke joins f...

More news and information about Tizona Therapeutics Inc

Published By:

Globe Newswire: 14:00 GMT Thursday 3rd January 2019

Published: .

Search for other references to "tizona" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us